Inventor · disambiguated record
Yushma Bhurruth-Alcor
Also filed as: BHURRUTH-ALCOR YUSHMA
5 granted patents·2 pending applications·0 citations·filing 2015–2022
59Inventor score
Top patents by PatentIndex Score
7 records- 0163US10647706B2Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologiesGALDERMA RES & DEV·Filed 2019·Granted May 12, 2020·0 cites·13 claims
- 0252US11518767B2MTOR inhibitor compoundsGALDERMA RES & DEV·Filed 2020·Granted Dec 6, 2022·0 cites·10 claims
- 0351US11731973B2Substituted pyrazolo[3,4-d]pyrimidines as mTOR inhibitorsGALDERMA RES & DEV·Filed 2020·Granted Aug 22, 2023·0 cites·17 claims
- 0439US10287278B2Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologiesGALDERMA RES & DEV·Filed 2015·Granted May 14, 2019·0 cites·6 claims
- 0539US2024376074A1Nampt inhibitors and uses thereofREMEDY PLAN INC·Filed 2022·Application pending·0 cites
- 0637US10556883B2Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine and cosmeticsGALDERMA RES & DEV·Filed 2017·Granted Feb 11, 2020·0 cites·12 claims
- 0733US2023023124A1Cancer treatments targeting cancer stem cellsREMEDY PLAN INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yushma Bhurruth-Alcor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →